Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. MAIA
MAIA logo

MAIA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MAIA News

MAIA Biotechnology Reports Progress in THIO-101 Clinical Trial for NSCLC

4d agoNewsfilter

MAIA Biotechnology Raises $33 Million to Advance Clinical Trials

Apr 09 2026NASDAQ.COM

MAIA Biotechnology Secures $33 Million for Phase 3 Trial

Apr 08 2026seekingalpha

Biotech Landscape Update: Regulatory Approvals and Acquisitions

Apr 03 2026NASDAQ.COM

MAIA Biotechnology Reports Significant Progress in THIO-101 Trial

Apr 01 2026NASDAQ.COM

MAIA Biotechnology Reports Breakthrough in Lung Cancer Treatment

Mar 31 2026Newsfilter

MAIA Biotechnology Completes $30 Million Financing to Advance Clinical Development

Mar 05 2026Yahoo Finance

U.S. Stocks Decline Amid Ongoing Iran-U.S. Conflict

Mar 03 2026Benzinga

MAIA Biotechnology Shares Plunge 29% After $30M Offering Announcement

Mar 03 2026seekingalpha

Ouster Inc Reports Strong Q4 Results, Shares Surge

Mar 03 2026Benzinga

MAIA Biotechnology Prices Public Offering to Raise $30 Million

Mar 03 2026NASDAQ.COM

MAIA Biotechnology Raises $30 Million in Public Offering

Mar 03 2026Newsfilter

MAIA Biotechnology Secures $30 Million in Public Offering

Mar 03 2026Yahoo Finance

MAIA Biotechnology Launches Public Offering of Common Stock

Mar 02 2026Newsfilter

FDA Accelerates Oncology Drug Approvals, Boosting Market Potential

Feb 05 2026Newsfilter

Oncolytics Biotech Strengthens Leadership to Advance Clinical Programs

Jan 28 2026Newsfilter